服务热线
15339069646服务热线
15339069646| Item | Cat. No. | Type | Clone No |
| Anti-IL2RA/CD25 mAbs [Camidanlumab Biosimilar] (MABL-4497) | MABL-4497 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-IL18 mAbs [Camoteskimab Biosimilar] (MABL-4498) | MABL-4498 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-PDCD1/CD279/PD1 mAbs [Camrelizumab Biosimilar] (MABL-4499) | MABL-4499 | ELISA, FACS, Functional assay, in vivo binding | G4, Kappa |
| Anti-IL1B mAbs [Canakinumab Biosimilar] (MABL-4500) | MABL-4500 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-SARS-CoV-2 RBD mAbs [Canrivitug Biosimilar] (MABL-4501) | MABL-4501 | ELISA, FACS, Functional assay, in vivo binding | G1, Lambda |
| Anti-MUC1/PEM/EMA mAbs [Cantuzumab Biosimilar] (MABL-4502) | MABL-4502 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-VWF mAbs [Caplacizumab Biosimilar] (MABL-4503) | MABL-4503 | ELISA, FACS, Functional assay, in vivo binding | na, na |
| Anti-CCL2/MCP1 mAbs [Carlumab Biosimilar] (MABL-4504) | MABL-4504 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-ENG/CD105 mAbs [Carotuximab Biosimilar] (MABL-4505) | MABL-4505 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-IL27 mAbs [Casdozokitug Biosimilar] (MABL-4506) | MABL-4506 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-ERBB2/CD340/HER2 mAbs [Caxmotabart Biosimilar] (MABL-4507) | MABL-4507 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-PDL1/CD274 mAbs [Cemavafusp Biosimilar] (MABL-4508) | MABL-4508 | ELISA, FACS, Functional assay, in vivo binding | na, Kappa |
| Anti-TNFRSF8/CD30 mAbs [Brentuximab Biosimilar] (MABL-4477) | MABL-4477 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-IL12B/CLMFp40 mAbs [Briakinumab Biosimilar] (MABL-4478) | MABL-4478 | ELISA, FACS, Functional assay, in vivo binding | G1, Lambda |
| Anti-KIT/CD117 mAbs [Briquilimab Biosimilar] (MABL-4479) | MABL-4479 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-TNFSF4/CD134/CD252/OX40L;TNF/TNFA mAbs [Brivekimig1 Biosimilar] (MABL-4480) | MABL-4480 | ELISA, FACS, Functional assay, in vivo binding | na, na;na |
| Anti-ALB mAbs [Brivekimig2 Biosimilar] (MABL-4481) | MABL-4481 | ELISA, FACS, Functional assay, in vivo binding | na, na |
| Anti-LAG3/CD223 mAbs [Brivestobart Biosimilar] (MABL-4482) | MABL-4482 | ELISA, FACS, Functional assay, in vivo binding | G4, Kappa |
| Anti-IL17RA/CD217 mAbs [Brodalumab Biosimilar] (MABL-4483) | MABL-4483 | ELISA, FACS, Functional assay, in vivo binding | G2, Kappa |
| Anti-VEGFA mAbs [Brolucizumab Biosimilar] (MABL-4484) | MABL-4484 | ELISA, FACS, Functional assay, in vivo binding | na, Kappa |
联系我们
Copyright © 2012-2029 西安迈博睿（Mabioway）生物科技有限公司 版权所有
地址：陕西省西安市浐灞生态区广运潭大道南段4555号长安大学科技园4号楼A单元2层
电话：15339069646 邮箱：info@mabioway.cn